Impact of Tuberculosis Prevention Therapy Policies on Quality of Life Among Patients in Surakarta, Indonesia

Rita Benya Adriani; Bhisma Murti; Dwi Sulistyowati; Happy Indri Hapsari

doi:10.25159/2520-5293/18630

Authors

Rita Benya Adriani School of Health Polytechnics, Ministry of Health
Bhisma Murti Universitas Sebelas Maret
Dwi Sulistyowati School of Health Polytechnics, Ministry of Health
Happy Indri Hapsari Kusuma Husada University

DOI:

https://doi.org/10.25159/2520-5293/18630

Keywords:

tuberculosis prevention, therapy policy, social support, personal stigma, quality of life

Abstract

Tuberculosis (TB) is a chronic infectious disease that affects millions of people worldwide. This article aims to examine the impact of TB prevention therapy policies on social support, medication adherence, personal stigma, and quality of life among TB patients in Surakarta, Indonesia. This is a quasi-experimental study using a pretest–posttest design involving 88 TB patients who visited the primary health centre in Mojosongo Village, Surakarta, Indonesia, from March to October 2023. This study employed a purposive sampling approach, specifically targeting TB patients attending primary health centres. Participants completed the Tuberculosis-Related Stigma Scale, Morisky Medication Adherence Questionnaire, Family Support Questionnaire, and World Health Organization Quality of Life–BREF (WHOQOL–BREF) questionnaire before and after the intervention. The study design included one-group pretest–posttest. Data analysis was performed using SPSS 22.0, applying independent samples t-test for mean comparisons and Pearson correlation coefficient to examine relationships between scale scores. The results showed a significant average difference between pretest and posttest scores on stigma, social support, medication adherence, and quality of life (QOL) for the experimental group (p = 0.0001), as well as stigma for the control group (p = 0.0001). There were also significant mean differences between the experimental group and the control group on stigma, medication adherence, and QOL (p = 0.0001). In addition, Pearson correlation showed a significant relationship between TB prevention therapy policies on stigma, medication adherence, and QOL (p = 0.0001). The findings of this study show that TB preventive therapy policies have a positive effect on social support, medication adherence, personal stigma, and quality of life for TB patients.

References

Aggarwal, A. N. 2019. “Quality of Life with Tuberculosis.” Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 15: 100096. https://doi.org/10.1016/j.jctube.2019.100096.

Alipanah, N., L. Jarlsberg, C. Miller, N. N. Linh, D. Falzon, E. Jaramillo, and P. Nahid. 2018. “Adherence Interventions and Outcomes of Tuberculosis Treatment: A Systematic Review and Meta-analysis of Trials and Observational Studies.” PLoS Medicine 15 (7): e1002595. https://doi.org/10.1371/journal.pmed.1002595.

Centers for Disease Control and Prevention. 2014. Managing Tuberculosis Patients and Improving Adherence. https://www.who.int/publications/i/item/9789240013131.

Chen, X., L. Du, R. Wu, J. Xu, H. Ji, Y. Zhang, X. Zhu, and L. Zhou. 2020. “The Effects of Family, Society and National Policy Support on Treatment Adherence among Newly Diagnosed Tuberculosis Patients: A Cross-Sectional Study.” BMC Infectious Diseases 20 (1): 623. https://doi.org/10.1186/s12879-020-05354-3.

Cohen, S., and T. A. Wills. 1985. “Stress, Social Support, and the Buffering Hypothesis.” Psychological Bulletin 98 (2): 310–57. https://doi.org/10.1037//0033-2909.98.2.310.

Craig, G. M., A. Daftary, N. Engel, S. O’Driscoll, and A. Ioannaki. 2017. “Tuberculosis Stigma as a Social Determinant of Health: A Systematic Mapping Review of Research in Low Incidence Countries.” International Journal of Infectious Diseases 56: 90–100. https://doi.org/10.1016/j.ijid.2016.10.011.

Datiko, D. G., D. Jerene, and P. Suarez. 2020. “Stigma Matters in Ending Tuberculosis: Nationwide Survey of Stigma in Ethiopia.” BMC Public Health 20 (1): 190. https://doi.org/10.1186/s12889-019-7915-6.

de Almeida Crispim, J., L. M. C. da Silva, M. Yamamura, M. P. Popolin, A. C. V. Ramos, L. H. Arroyo, A. A. R. de Queiroz, et al. 2017. “Validity and Reliability of the Tuberculosis-Related Stigma Scale Version for Brazilian Portuguese.” BMC Infectious Diseases 17 (1): 510. https://doi.org/10.1186/s12879-017-2615-2.

DeSanto, D., K. Velen, R. Lessells, S. Makgopa, D. Gumede, K. Fielding, A. D. Grant, et al. 2023. “A Qualitative Exploration into the Presence of TB Stigmatization across Three Districts in South Africa.” BMC Public Health 23 (1): 504. https://doi.org/10.1186/s12889-023-15407-2.

Earnshaw, V. A., and S. R. Chaudoir. 2009. “From Conceptualizing to Measuring HIV Stigma: A Review of HIV Stigma Mechanism Measures.” AIDS and Behavior 13 (6): 1160–177. https://doi.org/10.1007/s10461-009-9593-3.

Foster, I., M. Galloway, W. Human, M. Anthony, H. Myburgh, N. Vanqa, D. T. Wademan, et al. 2022. “Analysing Interventions Designed to Reduce Tuberculosis-Related Stigma: A Scoping Review.” PLOS Global Public Health 2 (10): e0000989. https://doi.org/10.1371/journal.pgph.0000989.

Harries, A. D., A. M. V. Kumar, S. Satyanarayana, P. Thekkur, Y. Lin, R. A. Dlodlo, M. Khogali, and R. Zachariah. 2020. “The Growing Importance of Tuberculosis Preventive Therapy and How Research and Innovation Can Enhance Its Implementation on the Ground.” Tropical Medicine and Infectious Disease 5 (2). https://doi.org/10.3390/tropicalmed5020061.

Kalfoss, M. H., R. J. Reidunsdatter, C. A. Klöckner, and M. Nilsen. 2021. “Validation of the WHOQOL-Bref: Psychometric Properties and Normative Data for the Norwegian General Population.” Health and Quality of Life Outcomes 19 (1): 13. https://doi.org/10.1186/s12955-020-01656-x.

Lestari, T., S. Graham, C. van den Boogard, R. Triasih, J. R. Poespoprodjo, R. R. Ubra, E. Kenangalem, et al. 2019. “Bridging the Knowledge-Practice Gap in Tuberculosis Contact Management in a High-Burden Setting: A Mixed-Methods Protocol for a Multicenter Health System Strengthening Study.” Implementation Science 14 (1): 31. https://doi.org/10.1186/s13012-019-0870-x.

Lisum, K., A. Waluyo, and A. Y. Nursasi. 2021. “Treatment Adherence among Tuberculosis Patients: A Concept Analysis.” Open Access Macedonian Journal of Medical Sciences 9 (T5 SE - Infective Diseases): 20–28. https://doi.org/10.3889/oamjms.2021.7849.

Morisky, D. E., A. Ang, M. Krousel-Wood, and H. J. Ward. 2008. “Predictive Validity of a Medication Adherence Measure in an Outpatient Setting.” Journal of Clinical Hypertension 10 (5): 348–54. https://doi.org/10.1111/j.1751-7176.2008.07572.x.

Nuttall, C., A. Fuady, H. Nuttall, K. Dixit, M. Mansyur, and T. Wingfield. 2022. “Interventions Pathways to Reduce Tuberculosis-Related Stigma: A Literature Review and Conceptual Framework.” Infectious Diseases of Poverty 11 (1): 101. https://doi.org/10.1186/s40249-022-01021-8.

Puspitasari, L., B. Murti, and A. Demartoto. 2016. “Social Support on the Adherence to Treatment of Tuberculosis in Cilacap, Indonesia.” Journal of Epidemiology and Public Health 1 (1): 58–65. https://www.jepublichealth.com/index.php/jepublichealth/article/view/10.

Seonmi, Y., K. J. Hee, and Y. Youngran. 2021. “Concept Analysis of Self-Stigma in Patients with Tuberculosis.” Journal of Korean Academy of Community Health Nursing 32 (3): 312–24. https://doi.org/10.12799/jkachn.2021.32.3.312.

Setiyowati, E., E. M. Wardani, N. Ainiyah, S. Damawiyah, and N. N. Juliasih. 2022. “Relationship Between Stigma and Quality of Life in People with Pulmonary Tuberculosis in East Java, Indonesia.” Gaceta Medica de Caracas 130 (5): S928–S935. https://doi.org/10.47307/GMC.2022.130.s5.10.

Shahin, W., G. A. Kennedy, and I. Stupans. 2021. “The Association Between Social Support and Medication Adherence in Patients with Hypertension: A Systematic Review.” Pharmacy Practice 19 (2): 2300. https://doi.org/10.18549/PharmPract.2021.2.2300.

Shamputa, I. C., M. A. Law, C. Kelly, D. T. K. Nguyen, T. Burdo, J. Umar, K. Barker, and D. Webster. 2023. “Tuberculosis Related Barriers and Facilitators among Immigrants in Atlantic Canada: A Qualitative Study.” PLOS Global Public Health 3 (6): e0001997. https://doi.org/10.1371/journal.pgph.0001997.

Teo, A. K. J., R. K. J. Tan, C. Smyth, V. Soltan, S. Eng, C. Ork, N. Sok, et al. 2020. “Characterizing and Measuring Tuberculosis Stigma in the Community: A Mixed-Methods Study in Cambodia.” Open Forum Infectious Diseases 7 (10): ofaa422. https://doi.org/10.1093/ofid/ofaa422.

Wen, S., J. Yin, and Q. Sun. 2020. “Impacts of Social Support on the Treatment Outcomes of Drug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis.” BMJ Open 10 (10): e036985. https://doi.org/10.1136/bmjopen-2020-036985.

World Health Organization (WHO). 2003. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization. https://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf.

World Health Organization (WHO). 2019. Global Tuberculosis Report 2019. Geneva: World Health Organization. https://www.who.int/publications-detail-redirect/global-tuberculosis-report-2019.

World Health Organization (WHO). 2020. WHO Consolidated Guidelines on Tuberculosis: Module 1: Prevention – Tuberculosis Preventive Treatment. Geneva: World Health Organization. https://www.who.int/publications/i/item/9789240001503.